세계의 폼페병 시장 : 투여 경로별, 최종 용도별, 치료 유형별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2023-2030년)

Pompe Disease Market, By Route of Administration, By End-Use, By Treatment Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

US $ 3,250 ￦ 4,589,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 4,650 ￦ 6,565,000

PDF (5 User License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,650 ￦ 7,977,000

PDF & Excel (Enterprise User License)

PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계 폼페병 시장 규모는 2022년 13억 2,223만 달러로 2023년부터 2030년까지 CAGR 4.2%로 확대될 것으로 예상됩니다.

폼페병 시장 - 시장 역학

• 제약사, 연구기관, 환자 지원 단체 간 협력 관계 확대가 시장 수요를 촉진
• 폼페병 연구와 치료의 발전은 제약회사, 학계, 펨페병 환자 지원 단체 간의 협력 확대에 의해 크게 촉진될 것입니다. 이러한 협력의 시너지 효과는 지식, 전문 지식 및 자원의 교환을 촉진하고 혁신적인 치료법 발견을 촉진할 수 있습니다. 규제 기관은 희귀질환 연구에 투자하는 기업의 인센티브를 높이기 위해 장려금과 희귀질환 치료제 지정을 제공하고 있습니다. 또한, 환자 지원 단체는 일반 대중의 인식을 높이고 연구 및 임상시험에 필요한 자금을 마련하기 위해 모금 활동을 조직하는 등 매우 중요한 역할을 하고 있습니다. 이러한 노력은 폼페병의 근본적인 원인에 대한 이해를 높이고, 맞춤형 치료법 개발의 길을 열어 궁극적으로 폼페병 환자들의 예후와 삶의 질을 개선하는 데 도움이 될 것입니다.

폼페병 시장 - 세분화 분석

• 세계 폼페병 시장은 투여 경로, 최종 용도, 치료 유형, 지역 등 다양한 요인에 따라 세분화를 제시합니다.
• 투여 경로별로는 비경구 투여가 시장을 주도하고 있습니다. 이는 희귀 유전성 질환인 폼페병의 관리에 있어 비경구적 치료법이 선호되고 있음을 보여줍니다. 정맥주사를 통한 효소대체요법(ERT)은 질환 관리에 있어 매우 중요한 역할을 하고 있습니다. 이 치료법은 결핍된 효소를 직접 투여하여 세포 내 글리코겐 축적을 효과적으로 처리하여 환자의 근육 기능을 개선합니다.

폼페병 시장 - 경쟁 상황

폼페병 연구 및 치료 시장은 제약회사, 연구기관 및 지원단체의 역동적인 상호작용이 특징입니다. 학술 단체와의 협력 관계는 과학적 진보를 촉진하고, 환자 지원 단체는 인지도를 높이고, 연구 활동에 자금을 지원하고, 규제 당국의 지원을 옹호하는 데 매우 중요한 역할을 합니다. 희귀질환 의약품 지정은 이 분야의 경쟁력을 더욱 강화합니다. 이러한 경쟁 환경 속에서 기업들은 치료 효과, 접근성, 환자 지원 이니셔티브의 실행을 강조함으로써 타사와의 차별화를 위해 노력하고 있습니다. 이러한 경쟁은 진보를 가속화하는 촉매제 역할을 하며, 더 넓은 치료 옵션과 폼페병 환자에게 제공되는 치료의 질을 전반적으로 향상시킬 수 있습니다.

목차

제1장 폼페병 시장 개요

• 조사 범위
• 시장 추정 연수

제2장 주요 요약

• 시장 내역
• 경쟁 인사이트

제3장 폼페병 주요 시장 동향

• 시장 성장 촉진요인
• 시장 성장 억제요인
• 시장 기회
• 향후 시장 동향

제4장 폼페병 산업 조사

• PEST 분석
• Porter's Five Forces 분석
• 성장 전망 매핑
• 규제 체계 분석

제5장 폼페병 시장 : COVID-19의 영향 분석

• 신종 코로나바이러스 감염증 이전의 영향 분석
• 신종 코로나바이러스 감염증 후의 영향 분석

제6장 폼페병 시장 상황

• 폼페병 시장 점유율 분석, 2022년
• 주요 제조업체별 내역 데이터
  • 기존 기업 분석
  • 신흥 기업 분석

제7장 폼페병 시장 - 투여 경로별

• 개요
  • 투여 경로별 부문 점유율 분석
  • 경구
  • 비경구

제8장 폼페병 시장 - 치료 유형별

• 개요
  • 치료 유형별 부문 점유율 분석
  • 기질 제거 요법(SRT)
  • 효소보충요법(ERT)
  • 기타

제9장 폼페병 시장 - 최종사용자별

• 개요
  • 최종사용자별 부문 점유율 분석
  • 병원
  • 외래 수술 센터
  • 기타

제10장 폼페병 시장 - 지역별

• 서론
• 북미
  • 개요
  • 북미의 주요 제조업체
  • 미국
  • 캐나다
• 유럽
  • 개요
  • 유럽의 주요 제조업체
  • 독일
  • 이탈리아
  • 영국
  • 프랑스
  • 러시아
  • 네덜란드
  • 스웨덴
  • 폴란드
  • 기타
• 아시아태평양
  • 개요
  • 아시아태평양의 주요 제조업체
  • 인도
  • 중국
  • 일본
  • 한국
  • 호주
  • 태국
  • 인도네시아
  • 필리핀
  • 기타
• 라틴아메리카
  • 개요
  • 라틴아메리카의 주요 제조업체
  • 브라질
  • 멕시코
  • 아르헨티나
  • 콜롬비아
  • 기타
• 중동 및 아프리카
  • 개요
  • 중동 및 아프리카의 주요 제조업체
  • 사우디아라비아
  • 아랍에미리트
  • 이스라엘
  • 터키
  • 알제리
  • 이집트
  • 기타

제11장 주요 벤더 분석 - 폼페병 산업

• 경쟁 대시보드
• 기업 개요
  • Sanofi Genzyme
  • Amicus Therapeutics
  • BioMarin Pharmaceutical
  • Ultragenyx Pharmaceutical
  • Audentes Therapeutics
  • Avrobio
  • Regenxbio
  • EpiVax
  • Selecta Biosciences
  • Cytokinetics
  • Adverum Biotechnologies
  • Audentes Therapeutics
  • JCR Pharmaceuticals
  • Audentes Therapeutics
  • Valerion Therapeutics

제12장 애널리스트의 전방위 전망

ksm

영문 목차

영문목차

REPORT HIGHLIGHT

Pompe Disease Market size was valued at USD 1,322.23 Million in 2022, expanding at a CAGR of 4.2% from 2023 to 2030.

Pompe disease, a rare genetic disorder, arises from a deficiency of the enzyme acid alpha-glucosidase (GAA). This deficiency leads to the accumulation of glycogen within cells, with the most pronounced impact on muscle tissues, resulting in a gradual loss of function. Symptoms commonly associated with this condition encompass muscle weakness, respiratory challenges, and cardiac complications. The disease's severity varies, with some individuals experiencing early-onset forms that can have life-threatening cardiac and muscular consequences, while others may have a later onset characterized primarily by muscle weakening. Pompe disease underscores the crucial importance of early detection and ongoing medical management to mitigate its impact on an individual's overall quality of life.

Pompe Disease Market - Market Dynamics:

• Growing collaboration between pharmaceutical companies, research institutions, and patient advocacy groups to propel market demand

• The advancement of research and treatment for Pompe disease is significantly propelled by the increasing collaboration among pharmaceutical companies, academic institutions, and advocacy organizations dedicated to patients with this condition. This collaborative synergy facilitates the exchange of knowledge, expertise, and resources, thereby expediting the discovery of innovative therapies. Regulatory bodies provide incentives and orphan drug designations to incentivize companies to invest in rare disease research. Additionally, patient advocacy groups play a pivotal role by raising public awareness and organizing fundraising initiatives that generate funds for research and clinical trials. This collective endeavor enhances our understanding of the disease's underlying causes and paves the way for the development of personalized treatments, ultimately improving the prognosis and quality of life for individuals affected by Pompe disease.

Pompe Disease Market - Key Insights:

• Our research analyst estimates that the global Pompe Disease market is poised for annual growth at a CAGR of approximately 4.2% during the forecast period from 2023 to 2030. This projected growth is attributed to the increasing collaboration among pharmaceutical firms, research institutions, and patient advocacy groups, indicating a positive trend toward advancing Pompe Disease research and treatment.

• The Global Pompe Disease Market is categorized based on various factors, including Route of Administration, End-Use, and Region.

• Within the Route of Administration category, Parenteral administration stood out as the dominant segment in the year 2022. This indicates a significant preference for this mode of administration in treating Pompe Disease.

• In terms of End-Use segmentation, Hospitals took the lead in 2022. This suggests that hospitals play a crucial role in providing medical care and treatment for Pompe Disease patients.

• Moreover, North America emerged as the primary revenue generator in 2022 among different regions.

Pompe Disease Market- Segmentation Analysis:

• The Global Pompe Disease Market presents segmentation based on various factors, including Route of Administration, End-Use, Treatment Type, and Region.

• Among the categories determined by Route of Administration, the Parenteral sector takes the lead in market dominance. This indicates a prevalent preference for parenteral treatments in managing Pompe disease, a rare genetic disorder. The administration of enzyme replacement therapy (ERT) through intravenous injections plays a pivotal role in disease management. This therapy directly delivers the deficient enzyme, effectively addressing glycogen accumulation within cells, and thereby improving muscle function in affected individuals.

Pompe Disease Market- Competitive Landscape:

The landscape of Pompe disease research and treatment is characterized by a dynamic interplay among pharmaceutical companies, research institutions, and advocacy groups. Collaborative efforts with academic organizations foster scientific advancements, while patient advocacy groups play a pivotal role in raising awareness, funding research endeavors, and advocating for regulatory support. The orphan drug designation further incentivizes competitiveness within the field. In this competitive environment, companies strive to set themselves apart by emphasizing treatment efficacy, accessibility, and the implementation of patient support initiatives. This competition acts as a catalyst for accelerated progress, leading to a broader range of therapeutic options and an overall enhancement in the quality of care provided to individuals with Pompe disease.

Recent Developments:

In June 2023, Amicus Therapeutics, a globally oriented biotechnology firm with a patient-centered approach, specializing in the development and commercialization of innovative medications for rare diseases, announced a significant milestone. The European Commission (EC) granted approval for Opfolda (miglustat) 65mg capsules, an enzyme stabilizer for cipaglucosidase alfa, as a long-term enzyme replacement therapy for adults afflicted with late-onset Pompe disease.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL POMPE DISEASE MARKET KEY PLAYERS

• Sanofi Genzyme
• Amicus Therapeutics
• BioMarin Pharmaceutical
• Ultragenyx Pharmaceutical
• Audentes Therapeutics
• Avrobio
• Regenxbio
• EpiVax
• Selecta Biosciences
• Cytokinetics
• Adverum Biotechnologies
• Audentes Therapeutics
• JCR Pharmaceuticals
• Audentes Therapeutics
• Valerion Therapeutics

GLOBAL POMPE DISEASE MARKET, BY ROUTE OF ADMINISTRATION

• Oral
• Parenteral

GLOBAL POMPE DISEASE MARKET, BY END-USE

• Hospitals
• Ambulatory Surgical Centers
• Other

GLOBAL POMPE DISEASE MARKET, BY TREATMENT TYPE

• Substrate Reduction Therapy (SRT)
• Enzyme Replacement Therapy (ERT)
• Other

GLOBAL POMPE DISEASE MARKET, BY REGION

• North America
• The U.S.
• Canada

• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe

• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC

• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM

• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Pompe Disease Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Pompe Disease Market Snippet by Route of Administration
  • 2.1.2. Pompe Disease Market Snippet by Treatment Type
  • 2.1.3. Pompe Disease Market Snippet by End-User
  • 2.1.4. Pompe Disease Market Snippet by Country
  • 2.1.5. Pompe Disease Market Snippet by Region
• 2.2. Competitive Insights

3. Pompe Disease Key Market Trends

• 3.1. Pompe Disease Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Pompe Disease Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Pompe Disease Market Opportunities
• 3.4. Pompe Disease Market Future Trends

4. Pompe Disease Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Pompe Disease Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Pompe Disease Market Landscape

• 6.1. Pompe Disease Market Share Analysis, 2022
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Pompe Disease Market - By Route of Administration

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
  • 7.1.2. Oral
  • 7.1.3. Parenteral

8. Pompe Disease Market - By Treatment Type

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Treatment Type, 2022 & 2030 (%)
  • 8.1.2. Substrate Reduction Therapy (SRT)
  • 8.1.3. Enzyme Replacement Therapy (ERT)
  • 8.1.4. Other

9. Pompe Disease Market - By End-User

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
  • 9.1.2. Hospitals
  • 9.1.3. Ambulatory Surgical Centers
  • 9.1.4. Other

10. Pompe Disease Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. Pompe Disease Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. Pompe Disease Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3.8. Italy
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.8.3. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.8.4. Italy Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3.9. United Kingdom
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.9.3. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.9.4. United Kingdom Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3.10. France
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.10.3. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.10.4. France Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3.11. Russia
    • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.11.2. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.11.3. Russia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3.12. Netherlands
    • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.12.2. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.12.3. Netherlands Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3.13. Sweden
    • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.13.2. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.13.3. Sweden Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3.14. Poland
    • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.14.2. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.14.3. Poland Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3.15. Rest of Europe
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. Pompe Disease Key Manufacturers in Asia Pacific
  • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.4.4. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.4.5. Asia Pacific Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4.7. India
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.7.3. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.7.4. India Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4.8. China
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.8.3. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.8.4. China Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.9.3. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.9.4. Japan Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.10.3. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.10.4. South Korea Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4.12. Thailand
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.12.3. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.12.4. Thailand Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4.13. Indonesia
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.13.3. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.13.4. Indonesia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
• 10.5. Latin America
  • 10.5.1. Overview
  • 10.5.2. Pompe Disease Key Manufacturers in Latin America
  • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.5.4. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.5.5. Latin America Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  • 10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
• 10.6. Middle East and Africa
  • 10.6.1. Overview
  • 10.6.2. Pompe Disease Key Manufacturers in Middle East and Africa
  • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.6.4. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.6.5. Middle East and Africa Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6.8. United Arab Emirates
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Pompe Disease Industry

• 11.1. Competitive Dashboard
• 11.2. Company Profiles
  • 11.2.1. Sanofi Genzyme
  • 11.2.2. Amicus Therapeutics
  • 11.2.3. BioMarin Pharmaceutical
  • 11.2.4. Ultragenyx Pharmaceutical
  • 11.2.5. Audentes Therapeutics
  • 11.2.6. Avrobio
  • 11.2.7. Regenxbio
  • 11.2.8. EpiVax
  • 11.2.9. Selecta Biosciences
  • 11.2.10. Cytokinetics
  • 11.2.11. Adverum Biotechnologies
  • 11.2.12. Audentes Therapeutics
  • 11.2.13. JCR Pharmaceuticals
  • 11.2.14. Audentes Therapeutics
  • 11.2.15. Valerion Therapeutics

12. 360 Degree Analyst View

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us

관련자료